Related Experiment Video
Updated: May 6, 2026

10:46
Doppler Optical Coherence Tomography of Retinal Circulation
Published on: September 18, 2012
19.3K
Automated diabetic retinopathy classification using vision transformers on optical confocal microscopy images
Applied Optics
|March 17, 2026
Summary
This study used a Vision Transformer to accurately detect diabetic retinopathy (DR) in retinal images, achieving 100% test accuracy. The AI model shows promise for clinical use in diagnosing DR.
Area of Science:
- Ophthalmology
- Artificial Intelligence
- Medical Imaging
Background:
- Diabetic retinopathy (DR) is a leading cause of vision loss.
- Early detection and diagnosis of DR are crucial for effective management.
- Automated diagnostic tools can aid clinicians in identifying DR.
Purpose of the Study:
- To evaluate the efficacy of the Vision Transformer architecture for classifying diabetic retinopathy in retinal images.
- To assess the model's performance on a dataset of normal and abnormal retinal images.
- To determine the potential of the AI model for clinical application in DR screening.
Main Methods:
- Utilized the Vision Transformer deep learning architecture.
- Trained and validated the model on a dataset of retinal images categorized as 'normal' or 'abnormal'.
- Evaluated model performance using accuracy, precision, recall, and F1-scores over 30 epochs.
Main Results:
- Achieved high training (98.91%), validation (98.79%), and perfect test accuracy (100%).
- Demonstrated perfect classification performance with precision, recall, and F1-scores of 1.00 for both classes on the test set.
- Observed consistent accuracy improvements and loss reductions during the 30-epoch training process.
Conclusions:
- The Vision Transformer model shows high potential for accurate diabetic retinopathy detection in clinical settings.
- The model's performance suggests it can be a valuable tool for assisting healthcare professionals in DR diagnosis.
- Future research should focus on improving model generalizability and integrating additional clinical data.

